Evaluating the Use of GLP-1 Receptor Agonists in Wolfram syndrome Patients
We conducted a retrospective cohort study of 84 participants with genetically confirmed Wolfram syndrome and insulin-dependent diabetes mellitus enrolled in the Washington University Wolfram Syndrome International Registry and Clinical Study.
You must be logged in to post a comment.